Why the study?
What are the preferences and concerns of VTE patients regarding anticoagulant therapy?
Population
24 VTE patients, mean age 45.7 years, 83% female.
Design
Cross-sectional
Authors
Loading...
Patient preferences for VTE anticoagulants warrant attention in shared decisions; leaves open how best to integrate them into practice.
What are the preferences and concerns of VTE patients regarding anticoagulant therapy?
VTE patients prioritize anticoagulant reversibility and monitoring capabilities, and are most concerned about recurrent VTE and mortality rather than the inconvenience of regular blood testing.
Lutsey et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: